Carcinoma in situ of lung (disorder)
CONCORDE: A Platform study of DNA damage response inhibitors in combination with conventional radiotherapy in non small cell lung cancer
Year Started: 2021
Archival tumour biopsies, Circulating Free DNA (cfDNA), Peripheral Blood Mononuclear Cell (PBMC), Toxicity Biomarkers
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Undifferentiated
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Whole blood | -60°C to -85°C | Not applicable | 0 - 10% |
Undifferentiated
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Whole blood | -60°C to -85°C | Not applicable | 0 - 10% |
Undifferentiated
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Whole blood | -60°C to -85°C | Not applicable | 0 - 10% |